Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms
Open accessAbstract
The p53 protein maintains genomic integrity through its ability to induce cell cycle arrest or apoptosis in response to various forms of stress. Substantial regulation of p53 activity occurs at the level of protein stability, largely determined by the activity of the Mdm2 protein. Mdm2 targets both p53 and itself for ubiquitylation and subsequent proteasomal degradation by acting as an ubiquitin ligase, a function that needs an intact Mdm2 RING finger. For efficient degradation of p53 nuclear export appears to be required. The Mdmx protein, structurally homologous to Mdm2, does not target p53 for degradation, but even stabilizes both p53 and Mdm2, an activity most likely mediated by heterodimerization of the RING fingers of Mdm2 and Mdmx. Here we show that Mdmx expression leads to accumulation of ubiquitylated, nuclear p53 but does not significantly affect the Mdm2-mediated ubiquitylation of p53. In contrast, Mdmx stabilizes Mdm2 by inhibiting its self-ubiquitylation.
AI snapshot
Written from the paper’s full text.
TL;DR
Mdmx stabilizes p53 and Mdm2 through distinct mechanisms: it promotes accumulation of ubiquitylated nuclear p53 without substantially blocking Mdm2-mediated p53 ubiquitylation, while it stabilizes Mdm2 by inhibiting Mdm2 self-ubiquitylation. Mdmx does not stabilize cytoplasmic p53, but it does stabilize cytoplasmic Mdm2.
Key findings
- Mdmx expression led to accumulation of ubiquitylated p53 and inhibited Mdm2-dependent p53 degradation, but did not detectably change the overall pattern of Mdm2-dependent p53 ubiquitylation in H1299 cells; in Saos-2 and p53/mdm2 double-knockout cells, Mdmx caused some relative reduction of slower-migrating ubiquitylated p53 forms.
- Mdmx stabilized Mdm2 by inhibiting its self-ubiquitylation: co-expression of Mdmx significantly reduced poly-ubiquitylated Mdm2 despite increased total Mdm2 levels, and increased the fastest-migrating lower ubiquitylated forms of Mdm2.
- In Saos-2 cells, mutant p53 alone was 49% exclusively nuclear and 50% strong nuclear with weak cytoplasmic staining; Mdm2 increased cytoplasmic p53, and additional Mdmx co-expression significantly reversed this shift, indicating inhibition of Mdm2-mediated nuclear export of p53.
- Mdmx did not stabilize cytoplasmic p53(NLS−) in H1299 or Saos-2 cells, but it stabilized cytoplasmic Mdm2(NLS−) to the same extent as wild-type nuclear Mdm2; co-immunoprecipitation indicated Mdmx binds both wild-type Mdm2 and Mdm2(NLS−).
Methods
- In vivo ubiquitylation assays were performed in H1299, p53/mdm2 double-knockout, and Saos-2 cells transfected with p53, Mdm2, Mdmx, and His6-tagged ubiquitin expression vectors; cells were untreated or treated with 20 µM MG132 for 4 h starting 40 h after transfection, then His-purified ubiquitylated proteins or total lysates were analyzed by western blot.
- Immunofluorescence localization studies used Saos-2 cells transfected with p53, human mdm2, and human mdmx; in each experiment more than 100 cells were counted for p53 localization and categorized as only nuclear, strong nuclear/weak cytoplasmic, equal, or weak/no nuclear/strong cytoplasmic, with three independent experiments.
- Co-immunoprecipitation was performed with anti-Mdmx serum p56; 80% of lysate was immunoprecipitated and 10% loaded directly, with Mdm2 detected by 4B2 antibody.
Limitations
- The paper states that the mechanism by which Mdmx prevents relocalization of p53 into the cytoplasm remains unclear.
- The text makes evident that effects on p53 ubiquitylation vary by cell line: Mdmx did not detectably change the ubiquitylation pattern in H1299 cells but partly reduced slower-migrating ubiquitylated p53 forms in Saos-2 and double-knockout cells, and this partial inhibition was not sufficient to prevent degradation of cytoplasmic p53.
- The text makes evident reliance on transfected overexpression systems and notes some supporting observations as “not shown” or “data not shown” (e.g., mouse embryo fibroblasts, U2OS cells, Saos-2 Mdm2 ubiquitylation).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 23 cited sources checked · 0 supported · 0 flagged
- Findingown data
In Saos-2 cells, mutant p53 V143A transfected alone is predominantly nuclear (49% exclusively nuclear, 50% strong nuclear/weak cytoplasmic).
“When mutant p53 was transfected alone into Saos-2 cells, 49% of the p53 positive cells showed exclusively nuclear and 50% strong nuclear and weak cytoplasmic staining (Figure 2B, left).”
Quote in the paperSubstantial claim - Findingown data
Mdmx stabilizes Mdm2 by inhibiting its self-ubiquitylation.
“In contrast, Mdmx stabilizes Mdm2 by inhibiting its self-ubiquitylation.”
Quote in the paperSubstantial claim - Findingown data
In DKO cells, Mdmx causes some reduction in slower-migrating ubiquitylated forms of p53 relative to faster-migrating forms.
“However, in contrast to H1299 cells, in these cells this effect was accompanied by some reduction in the amount of slow migrating ubiquitylated forms of p53 relative to the faster migrating forms”
Quote in the paperNot a substantial claim - Findingown data
In H1299 cells, Mdmx does not significantly alter the ubiquitylation pattern of p53(NLS-) upon proteasome inhibition.
“Upon inhibition of the proteasome, Mdmx expression does not significantly alter the ubiquitylation pattern of p53(NLS -).”
Quote in the paperSubstantial claim - Findingown data
Mdmx expression does not significantly affect Mdm2-mediated ubiquitylation of p53.
“Here we show that Mdmx expression leads to accumulation of ubiquitylated, nuclear p53 but does not significantly affect the Mdm2-mediated ubiquitylation of p53.”
Quote in the paperSubstantial claim
- Findingown data
Mdmx increases the fastest-migrating lower ubiquitylated forms of Mdm2.
“In contrast to the polyubiquitylated forms, the amount of the fastest migrating lower ubiquitylated forms of Mdm2 was increased.”
Quote in the paperSubstantial claim - Findingown data
Cytoplasmic Mdm2 is stabilized by Mdmx to the same extent as wild-type nuclear Mdm2.
“In marked contrast to p53, cytoplasmic Mdm2 was stabilized by Mdmx (Figure 3A, panel 6 and Figure 3B) to the same extent as wild-type nuclear Mdm2 (Figure 3A, panel 17 and Figure 3B).”
Quote in the paperSubstantial claim - Findingown data
Co-expression of Mdm2 increases cytoplasmic p53 in Mdm2-positive cells.
“Coexpression of Mdm2 resulted in a clear increase in cytoplasmic p53 in the Mdm2-positive cells.”
Quote in the paperSubstantial claim - Findingown data
Co-expression of Mdmx reverses the Mdm2-induced cytoplasmic shift of p53.
“Additional co-expression of Mdmx reversed this shift significantly”
Quote in the paperSubstantial claim - Findingown data
Mdmx expression leads to accumulation of ubiquitylated p53 in the nucleus.
“Here we show that Mdmx expression leads to accumulation of ubiquitylated, nuclear p53 but does not significantly affect the Mdm2-mediated ubiquitylation of p53.”
Quote in the paperSubstantial claim - Findingown data
In the absence of MG132, Mdmx does not significantly increase ubiquitylated cytoplasmic p53.
“In the absence of MG132, Mdmx expression does not lead to a significant increase in the amount of ubiquitylated cytoplasmic p53, reflecting the fact that Mdmx is not stabilizing p53(NLS -).”
Quote in the paperSubstantial claim - Findingown data
With MG132, Mdmx reduces ubiquitylation of cytoplasmic p53 to a degree comparable or stronger than wild-type p53.
“When degradation is prevented by MG132, the expression of Mdmx does lead to some reduction of ubiquitylation of cytoplasmic p53, comparable or even stronger to that observed with wild-type p53.”
Quote in the paperSubstantial claim - Findingown data
In H1299 cells, Mdmx inhibits Mdm2-dependent degradation of p53.
“As observed previously, Mdmx inhibited the Mdm2-dependent degradation of p53 (Figure 1A, total lysate).”
Quote in the paperSubstantial claim - Findingown data
In Saos-2 and p53-deficient mouse embryo fibroblasts, Mdmx causes some relative reduction of slower-migrating ubiquitylated p53 forms, though less pronounced than in DKO cells.
“In both cases, some relative reduction of the slower migrating ubiquitylated forms of p53 scientific report could be observed, although somewhat less pronounced compared to the DKO cells.”
Quote in the paperSubstantial claim - Findingown data
In p53/mdm2 double knockout cells, Mdmx prevents Mdm2-dependent degradation of p53.
“As in H1299 cells, Mdmx prevents the degradation of p53 by Mdm2, (Figure 1B, total lysate, lanes 5, 6 compared with lanes 3, 4).”
Quote in the paperSubstantial claim - Findingreasoning
Mdmx differentially affects the ubiquitylation of Mdm2 and p53.
“It is intriguing that Mdmx differentially affects the ubiquitylation of Mdm2 and p53.”
Quote in the paperSubstantial claim - Findingown data
Mdmx does not stabilize cytoplasmic p53(NLS-) in H1299 or Saos-2 cells.
“However, Mdmx did not stabilize cytoplasmic p53(NLS -), neither in H1299 nor in Saos-2 cells (Figure 3A, panel 7, and Figure 3B)”
Quote in the paperSubstantial claim - Findingown data
Mdmx inhibits Mdm2-mediated nuclear export of p53.
“Mdmx inhibits Mdm2-mediated nuclear export of p53”
- Also stated in: § Mdmx inhibits Mdm2-mediated nuclear export of p53 · hedged
“Additional co-expression of Mdmx reversed this shift significantly, suggesting that Mdmx inhibited the Mdm2-mediated nuclear export of p53.”
Quote in the paperSubstantial claim - Also stated in: § Mdmx inhibits Mdm2-mediated nuclear export of p53 · hedged
- Findingown data
In Saos-2 cells, Mdmx marginally reduces polyubiquitylation of wild-type p53.
“In Saos-2 cells (Figure 3C, left panel), Mdmx again marginally reduced the poly-ubiquitylation of wild-type p53.”
Quote in the paperSubstantial claim - Interpretationreasoning
Targeting of Mdm2's ubiquitin ligase activity toward p53 or itself strongly depends on cellular environment, including ARF and Mdmx expression levels.
“In conclusion, these observations suggest that the targeting of ubiquitin ligase activity of Mdm2 towards p53 or itself is strongly dependent on the cellular environment, i.e. expression levels of ARF and Mdmx.”
Quote in the paperSubstantial claim - Interpretationreasoning
Mdm2 appears stabilized by inhibition of its autoubiquitylation.
“In contrast to the way Mdmx stabilizes p53, Mdm2 appears to be stabilized due to the inhibition of autoubiquitylation.”
Quote in the paperSubstantial claim - Premisecitation
Mdmx and Mdm2 interact via their RING finger domains.
“Mdmx and Mdm2 interact via their RING finger domains (Sharp et al., 1999;Stad et al., 2000)”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
The RING finger of Mdmx is needed for stabilization of p53.
“Since the RING finger of Mdmx is needed for stabilization of p53”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationown data
Mdmx prevents Mdm2-dependent p53 degradation by stabilizing nuclear ubiquitylated p53.
“These data are consistent with the previous results showing that Mdmx prevents Mdm2-dependent degradation of p53 by stabilization of nuclear, ubiquitylated p53, whereas Mdmx stabilizes Mdm2 independent of its localization, most likely by repressing its auto-ubiquitylation.”
Quote in the paperSubstantial claim - Interpretationreasoning
Mdmx stabilizes p53 primarily by sequestering ubiquitylated p53 in the nucleus.
“We provide evidence that the main mechanism by which Mdmx stabilizes p53 is through sequestration of ubiquitylated p53 in the nucleus”
Quote in the paperSubstantial claim - Premisecitation
For Mdm2 to ubiquitylate p53, its RING finger is essential.
“For Mdm2 to ubiquitylate p53 its RING finger is essential (Honda et al., 1997).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Honda et al., 1997 source
Not checked in the free run.
- Premisecitation
Mdmx is unable to shuttle from the nucleus to the cytoplasm.
“Since Mdmx is unable to shuttle from the nucleus to the cytoplasm (Jackson and Berberich, 2000)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Jackson and Berberich, 2000 source
Not checked in the free run.
- Interpretationreasoning
Ubiquitylation of p53 is not sufficient for its nuclear export.
“Our results indicate that ubiquitylation of p53 is not sufficient for its nuclear export.”
Quote in the paperSubstantial claim - Premisecitation
Mdmx-Mdm2 heterodimers form preferentially over their respective homodimers.
“Mdmx-Mdm2 heterodimers are preferentially formed over their respective homodimers (Sharp et al., 1999)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sharp et al., 1999 source
Not checked in the free run.
- Premisecitation
p53, Mdm2 and Mdmx can form a trimeric complex.
“p53, Mdm2 and Mdmx can form a trimeric complex (Stad et al., 2000).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Stad et al., 2000 source
Not checked in the free run.
- May combine two claims. 20
- The quote only partly states this claim. 1
- Classified as probably not a substantial claim. 3
May combine two claims.
Findingown dataIn p53/mdm2 double knockout cells, Mdmx does not cause accumulation of ubiquitylated p53, indicating Mdmx lacks intrinsic ubiquitin ligase activity toward p53.
“In the absence of endogenous Mdm2, Mdmx did not result in the accumulation of ubiquitylated p53 (Figure 1B, His purified, lanes 7, 8), indicating that Mdmx by itself does not have ubiquitin ligase activity towards p53.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataMdmx has similar effects on Hdm2 and in Saos-2 cells.
“A similar effect was observed with Hdm2, although the pattern of ubiquitylated Mdm2 and Hdm2 is somewhat different (Figure 1D, lanes 5-8).”
- Also stated in: § 2001; see Methods). · plain
“In addition, the same effect was observed in Saos-2 cells (not shown).”
Quote in the paperNot a substantial claim- Also stated in: § 2001; see Methods). · plain
May combine two claims.
Findingown dataAcross cell lines, Mdmx either does not (H1299) or only partly (Saos-2, DKO) prevent Mdm2-mediated polyubiquitylation of p53.
“Together, the data in Figure 1A-C show that, depending on the cell line tested, Mdmx does not (H1299) or partly (Saos-2, DKO) prevent Mdm2-mediated (poly-)ubiquitylation of p53.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn all tested cases, ubiquitylated p53 levels with both Mdm2 and Mdmx are higher than with p53 alone, indicating stabilization of ubiquitylated p53.
“In all cases, the amount of ubiquitylated p53 in the presence of both Mdm2 and Mdmx is higher than after transfection of only p53, indicating a stabilization of ubiquitylated p53.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataWith wild-type p53, Mdm2 has only a very limited effect on p53 localization, but Mdmx increases nuclear localization of p53.
“With the use of a wild-type p53 expression vector, the effect of Mdm2 on p53 localization is only very limited in our hands, but still in this case co-expression of Mdmx leads to an increase in nuclear localization of p53 (Figure 2B, right).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMdmx localization largely depends on Mdm2 localization, and Mdmx binds both wild-type and NLS-mutant Mdm2.
“since Mdmx localization was largely dependent on the localization of Mdm2 (Figure 3A panels 9, 10 and 20, 21) and co-immunoprecipitation studies indicate that Mdmx binds to both wild-type Mdm2 and the Mdm2(NLS -) mutant (Figure 3D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn H1299 cells, Mdmx causes a general increase in ubiquitylated p53 but does not detectably change the overall pattern of Mdm2-dependent p53 ubiquitylation.
“While Mdmx caused a general increase in the level of ubiquitylated p53 it did not detectably change the overall pattern of Mdm2-dependent ubiquitylation of p53 (Figure 1A, His purified, lanes 5, 6 compared to lanes 3, 4)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMdmx can block Mdm2-dependent p53 degradation without significantly affecting the pattern of p53 ubiquitylation.
“In this report we show that Mdmx can block Mdm2-dependent degradation of p53 without significantly affecting the pattern of p53 ubiquitylation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMdmx significantly reduces polyubiquitylated Mdm2 while total Mdm2 levels increase.
“Co-expression of Mdmx significantly reduced the amount of poly-ubiquitylated Mdm2 (Figure 1D, His purified, lane 3 and 4), despite the total levels of Mdm2 being increased (Figure 1D, total lysate, compare lanes 1, 2 with 3, 4).”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningMdmx can modestly affect p53 ubiquitylation in the absence of co-transfected Mdm2 only when endogenous Mdm2 is expressed, likely because Mdmx stabilizes endogenous Mdm2.
“Mdmx does not have intrinsic ubiquitin ligase activity and Mdmx can modestly affect p53 ubiquitylation in the absence of co-transfected Mdm2 only when endogenous Mdm2 is expressed, which is probably stabilized by the transfected Mdmx.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEfficient degradation of p53 requires its nuclear export.
“Several reports suggest that nuclear export of p53, mediated through the nuclear export signal (NES) of Mdm2 and/or through the NES of p53 itself, is required for its efficient degradation (Roth et al., 1998;Tao and Levine, 1999;Boyd et al., 2000;Geyer et al., 2000).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
Interpretationown dataMdmx stabilizes Mdm2 independent of its localization, most likely by repressing its auto-ubiquitylation.
“These data are consistent with the previous results showing that Mdmx prevents Mdm2-dependent degradation of p53 by stabilization of nuclear, ubiquitylated p53, whereas Mdmx stabilizes Mdm2 independent of its localization, most likely by repressing its auto-ubiquitylation.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataIn cells co-transfected with Mdm2 and Mdmx, MG132 does not further increase ubiquitylated p53, indicating Mdmx blocks proteasome-mediated degradation of ubiquitylated p53.
“In cells co-transfected with Mdm2 and Mdmx, MG132 had no further effect on the level of ubiquitylated p53, indicating that Mdmx blocks proteasome-mediated degradation of ubiquitylated p53.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMdmx does not target p53 for degradation but instead stabilizes p53 and Mdm2.
“However, Mdmx does not target p53 for degradation but even prevents Mdm2-mediated degradation of p53 and also stabilizes Mdm2 (Sharp et al., 1999;Jackson and Berberich, 2000;Stad et al., 2000).”
Quote in the paperSubstantial claim0 of 3 sources checkedClassified as probably not a substantial claim. May combine two claims.
PremisecitationMdm2 is a RING-type E3 ubiquitin ligase that ubiquitylates itself and p53, leading to their proteasomal degradation.
“Mdm2 is a RING-type E3 ubiquitin ligase (Honda et al., 1997;Fang et al., 2000;Honda and Yasuda, 2000), which directs the ubiquitylation of itself and p53.”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
Interpretationown dataPartial inhibition of Mdm2-mediated p53 ubiquitylation by Mdmx in Saos-2 is not sufficient to prevent p53 degradation; Mdmx stabilization of p53 requires nuclear localization.
“These results strongly indicate that the partial inhibition of Mdm2-mediated p53 ubiquitylation by Mdmx in Saos-2 is not sufficient to prevent the degradation of p53, but that stabilization of p53 by Mdmx is dependent on a nuclear localization.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationCo-expression of Mdm2 with p53 in Saos-2 or U2OS cells enhances nuclear export of p53, which is required for efficient degradation.
“Two recent reports suggest that co-expression of Mdm2 with p53 in Saos-2 or U2OS cells results in enhanced nuclear export of p53, required for its efficient degradation (Boyd et al., 2000;Geyer et al., 2000).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Interpretationown dataInhibition of p53 ubiquitylation by Mdmx in some cell lines is neither necessary nor sufficient for p53 stabilization.
“Although some inhibition of p53 ubiquitylation is observed in some cell lines, this effect appears neither necessary nor sufficient for the stabilization by Mdmx.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSwapping Mdm2's RING finger with Praja 1's RING finger did not affect Mdm2 ubiquitylation but prevented p53 ubiquitylation.
“This switch did not affect Mdm2 ubiquitylation but prevented the ubiquitylation of p53 (Fang et al., 2000).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fang et al., 2000 source
Not checked in the free run.
May combine two claims.
Premisecitationp14ARF stabilizes Mdm2 and blocks Mdm2-mediated p53 degradation, but its effects on p53 and Mdm2 ubiquitylation are opposite to Mdmx.
“While p14ARF also stabilizes Mdm2 and blocks Mdm2-mediated degradation of p53, its effects on p53 and Mdm2 ubiquitylation are the opposite of Mdmx.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xirodimas et al., 2001 source
Not checked in the free run.
May combine two claims.
Premisecitationp14ARF inhibits polyubiquitylation of p53 while Mdm2 ubiquitylation is unaffected.
“p14ARF inhibits the poly-ubiquitylation of p53 while the ubiquitylation of Mdm2 is unaffected (Xirodimas et al., 2001).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xirodimas et al., 2001 source
Not checked in the free run.
May combine two claims.
PremisecitationMdm2 S395D mutant is impaired in p53 degradation and strongly inhibited in stimulating p53 nuclear export, with preliminary data suggesting ubiquitin ligase activity not decreased.
“This effect was explained by the observation that the Mdm2 S395D mutant was strongly inhibited in its ability to stimulate nuclear export of p53, while preliminary data suggested that the ubiquitin ligase activity was not decreased.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Maya et al., 2001 source
Not checked in the free run.
The paper relies on this without support.
Poly-ubiquitylated proteins, rather than mono- or di-ubiquitylated proteins, are efficiently recognized and degraded by the proteasome.
“It has been shown that poly-ubiquitylated rather than mono-or di-ubiquitylated proteins are efficiently recognized and degraded by the proteasome.”
The paper relies on this without support.
Cytoplasmic p53 is efficiently ubiquitylated and degraded by cytoplasmic Mdm2.
“Cytoplasmic p53 is efficiently ubiquitylated and degraded by cytoplasmic Mdm2.”
The paper relies on this without support.
Heterodimerization of the RING fingers of Mdmx and Mdm2 is required for Mdmx's effects.
“Heterodimerization of the RING fingers of Mdmx and Mdm2 appears to be required for these effects, but the exact mechanism by which Mdmx operates has not been determined.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mdm4 contributes to Mdm2 stability by disrupting self-ubiquitination of Mdm2.
“Mdm4 further contributes to Mdm2 stability by disrupting self-ubiquitination of the latter (Stad et al., 2001), while also stimulating Mdm2-mediated polyubiquitination of p53 (Linares et al., 2003).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Stad et al., 2001
Mdmx is overexpressed in many human malignancies and, together with Mdm2, negatively regulates the p53 tumor suppressor.
“The oncogene Mdmx is overexpressed in many human malignancies, and together with Mdm2, negatively regulates the p53 tumor suppressor.”
From Mdmx promotes genomic instability independent of p53 and Mdm2 (2015) · cites this paper as [24]
Mdmx negatively regulates p53 by inhibiting p53 transcriptional activity rather than by promoting p53 degradation through ubiquitination.
“While Mdmx negatively regulates p53, it does so through inhibiting p53 transcriptional activity rather than promoting p53 degradation through ubiquitination, as is the case for Mdm2.24,25”
From Mdmx promotes genomic instability independent of p53 and Mdm2 (2015) · cites this paper as [24]
Through their RING domains, Mdmx binds Mdm2 and enhances Mdm2's ability to regulate p53.
“Additionally, it has been shown that through their RING domains, Mdmx binds Mdm2 and enhances the ability of Mdm2 to regulate p53.23,24,26–28”
From Mdmx promotes genomic instability independent of p53 and Mdm2 (2015) · cites this paper as [24]
MDMX binds p53 and inhibits its transcriptional function, but alone does not promote p53 ubiquitination or degradation in vivo.
“MDMX shares strong homology to MDM2 at the amino-acid sequence level and can bind to p53 and inhibit its transcriptional function.However, MDMX alone does not promote p53 ubiquitination or degradation in vivo (Stad et al, 2001).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Stad et al, 2001
MDMX lacks significant intrinsic E3 ligase activity.
“However, MDMX does not have significant intrinsic E3 ligase activity (Stad et al, 2001)”
From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Stad et al, 2001
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Figure 2A panel 3 is assigned opposite p53 localization patterns
MinorThe Figure 2 caption identifies panel 3 as both strong nuclear with weak cytoplasmic staining and weak or no nuclear with strong cytoplasmic staining.
“strong nuclear and weak cytoplasmic [N>C; (A), panel 3]”
“weak or no nuclear and strong cytoplasmic [N<C; (A), panel 3]”
Cites
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · see citing works
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · see citing works
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951 · see citing works
Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044 · see citing works
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage
Maya, R., Balass, M., Kim, S.-T., Shkedy, D., Leal, J.-F. M., Shifman, O., Moas, M., Buschmann, T., Ronai, Z., Shiloh, Y., et al. (2001) · Genes & Development · doi:10.1101/gad.886901 · Cited by 716 · see citing works
MDMX: a novel p53‐binding protein with some functional properties of MDM2.
Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00919.x · Cited by 648 · see citing works
Self-citationRoth, J., Dobbelstein, M., Freedman, D. A., Shenk, T., & Levine, A. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.554 · Cited by 610 · see citing works
Honda, R., & Yasuda, H. (2000) · Oncogene · doi:10.1038/sj.onc.1203464 · Cited by 376 · see citing works
The MDM2 RING-finger domain is required to promote p53 nuclear export
Geyer, R. K., Yu, Z. K., & Maki, C. G. (2000) · Nature Cell Biology · doi:10.1038/35023507 · Cited by 361 · see citing works
Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53
Tao, W., & Levine, A. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3077 · Cited by 355 · see citing works
An intact HDM2 RING-finger domain is required for nuclear exclusion of p53
Boyd, S. D., Tsai, K. Y., & Jacks, T. (2000) · Nature Cell Biology · doi:10.1038/35023500 · Cited by 334 · see citing works
Stabilization of the MDM2 Oncoprotein by Interaction with the Structurally Related MDMX Protein
Sharp, D. A., Kratowicz, S. A., Sank, M. J., & George, D. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38189 · Cited by 286 · see citing works
MdmX Protects p53 from Mdm2-Mediated Degradation
Jackson, M. W., & Berberich, S. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.1001-1007.2000 · Cited by 211 · cited 2× · see citing works
“Since Mdmx is unable to shuttle from the nucleus to the cytoplasm (Jackson and Berberich, 2000), we tested in a similar experiment whether Mdmx could affect this relocalization of p53.”
BackgroundDifferent effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo
Xirodimas, D., Saville, M. K., Edling, C., Lane, D. P., & Laín, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204656 · Cited by 169 · see citing works
Self-citationStad, R., Ramos, Y. F. M., Little, N., Grivell, S., Attema, J., van der Eb, A. J., & Jochemsen, A. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003496200 · Cited by 145 · see citing works
Self-citationThe contribution of the acidic domain of MDM2 to p53 and MDM2 stability
Argentini, M., Barboule, N., & Wasylyk, B. (2001) · Oncogene · doi:10.1038/sj.onc.1204241 · Cited by 90 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
p53 ubiquitination: Mdm2 and beyond
Brooks, C. L., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.020 · Cited by 924 · see citing works
Awakening guardian angels: drugging the p53 pathway
Brown, C. J., Lain, S., Verma, C. S., Fersht, A. R., & Lane, D. P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2763 · Cited by 881 · see citing works
Self-citationThe complexity of p53 stabilization and activation
Lavin, M. F., & Gueven, N. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401925 · Cited by 701 · see citing works
A dynamic role of HAUSP in the p53-Mdm2 pathway
Li, M., Brooks, C. L., Kon, N., & Gu, W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00157-1 · Cited by 679 · see citing works
Mdm2-Mediated NEDD8 Conjugation of p53 Inhibits Its Transcriptional Activity
Xirodimas, D. P., Saville, M. K., Bourdon, J.-C., Hay, R. T., & Lane, D. P. (2004) · Cell · doi:10.1016/j.cell.2004.06.016 · Cited by 570 · see citing works
Self-citationCoping with stress: multiple ways to activate p53
Horn, H. F., & Vousden, K. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210263 · Cited by 522 · see citing works
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
Linares, L. K., Hengstermann, A., Ciechanover, A., Müller, S., & Scheffner, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2030930100 · Cited by 361 · see citing works
Migliorini, D., Denchi, E. L., Danovi, D., Jochemsen, A., Capillo, M., Gobbi, A., Helin, K., Pelicci, P. G., & Marine, J.-C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5527-5538.2002 · Cited by 313 · see citing works
Self-citationDanovi, D., Meulmeester, E., Pasini, D., Migliorini, D., Capra, M., Frenk, R., de Graaf, P., Francoz, S., Gasparini, P., Gobbi, A., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5835-5843.2004 · Cited by 310 · see citing works
Self-citationLinke, K., Mace, P. D., Smith, C. A., Vaux, D. L., Silke, J., & Day, C. L. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402309 · Cited by 288 · see citing works
Pathological Unfoldomics of Uncontrolled Chaos: Intrinsically Disordered Proteins and Human Diseases
Uversky, V. N., Davé, V., Iakoucheva, L. M., Malaney, P., Metallo, S. J., Pathak, R. R., & Joerger, A. C. (2014) · Chemical Reviews · doi:10.1021/cr400713r · Cited by 288 · see citing works
Meulmeester, E., Maurice, M. M., Boutell, C., Teunisse, A. F. A. S., Ovaa, H., Abraham, T. E., Dirks, R. W., & Jochemsen, A. G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.024 · Cited by 260 · see citing works
Self-citationATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage
Chen, L., Gilkes, D. M., Pan, Y., Lane, W. S., & Chen, J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600812 · Cited by 260 · see citing works
Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia
Carvajal, L. A., Neriah, D. B., Senecal, A., Benard, L., Thiruthuvanathan, V., Yatsenko, T., Narayanagari, S.-R., Wheat, J. C., Todorova, T. I., Mitchell, K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao3003 · Cited by 249 · see citing works
MDM2 promotes ubiquitination and degradation of MDMX
Pan, Y., & Chen, J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5113-5121.2003 · Cited by 246 · see citing works
Marine, J.-C. W., Dyer, M. A., & Jochemsen, A. G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03362 · Cited by 228 · see citing works
Self-citationPoyurovsky, M. V., Priest, C., Kentsis, A., Borden, K. L., Pan, Z., Pavletich, N., & Prives, C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601465 · Cited by 203 · see citing works
Identification and Characterization of the First Small Molecule Inhibitor of MDMX
Reed, D., Shen, Y., Shelat, A. A., Arnold, L. A., Ferreira, A. M., Zhu, F., Mills, N., Smithson, D. C., Regni, C. A., Bashford, D., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056747 · Cited by 198 · see citing works
Self-citationLevels of HdmX expression dictate the sensitivity of normal and transformed cells to Nutlin-3
Patton, J. T., Mayo, L. D., Singhi, A. D., Gudkov, A. V., Stark, G. R., & Jackson, M. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3832 · Cited by 189 · see citing works
Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage
Pereg, Y., Shkedy, D., de Graaf, P., Meulmeester, E., Edelson-Averbukh, M., Salek, M., Biton, S., Teunisse, A. F. A. S., Lehmann, W. D., Jochemsen, A. G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408595102 · Cited by 181 · see citing works
Self-citationAn essential function of the extreme C-terminus of MDM2 can be provided by MDMX
Uldrijan, S., Pannekoek, W., & Vousden, K. H. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601469 · Cited by 170 · see citing works
ATM activates p53 by regulating MDM2 oligomerization and E3 processivity
Cheng, Q., Chen, L., Li, Z., Lane, W. S., & Chen, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.294 · Cited by 165 · see citing works
DNA damage-induced MDMX degradation is mediated by MDM2
Kawai, H., Wiederschain, D., Kitao, H., Stuart, J., Tsai, K. K. C., & Yuan, Z.-M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308295200 · Cited by 163 · see citing works
Regulation of p53 by the Ubiquitin-conjugating Enzymes UbcH5B/C in Vivo
Saville, M. K., Sparks, A., Xirodimas, D. P., Wardrop, J., Stevenson, L. F., Bourdon, J.-C., Woods, Y. L., & Lane, D. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403362200 · Cited by 158 · see citing works
Self-citationSynergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development
Xiong, S., Van Pelt, C. S., Elizondo-Fraire, A. C., Liu, G., & Lozano, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508500103 · Cited by 155 · see citing works
Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2
de Graaf, P., Little, N. A., Ramos, Y. F. M., Meulmeester, E., Letteboer, S. J. F., & Jochemsen, A. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213034200 · Cited by 143 · see citing works
MDMX regulation of p53 response to ribosomal stress
Gilkes, D. M., Chen, L., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601424 · Cited by 142 · see citing works
Regulation of p53: a collaboration between Mdm2 and MdmX
Pei, D., Zhang, Y., & Zheng, J. (2012) · Oncotarget · doi:10.18632/oncotarget.443 · Cited by 140 · see citing works
Okamoto, K., Kashima, K., Pereg, Y., Ishida, M., Yamazaki, S., Nota, A., Teunisse, A., Migliorini, D., Kitabayashi, I., Marine, J.-C., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9608-9620.2005 · Cited by 129 · see citing works
Self-citationRegulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122 · see citing works
USP7 Is a Master Regulator of Genome Stability
Valles, G. J., Bezsonova, I., Woodgate, R., & Ashton, N. W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00717 · Cited by 114 · see citing works
“Mdm4 further contributes to Mdm2 stability by disrupting self-ubiquitination of the latter (Stad et al., 2001), while also stimulating Mdm2-mediated polyubiquitination of p53 (Linares et al.”
BackgroundQuantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation
Wang, Y. V., Wade, M., Wong, E., Li, Y.-C., Rodewald, L. W., & Wahl, G. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701497104 · Cited by 116 · see citing works
Differential Roles of ATM- and Chk2-Mediated Phosphorylations of Hdmx in Response to DNA Damage
Pereg, Y., Lam, S., Teunisse, A., Biton, S., Meulmeester, E., Mittelman, L., Buscemi, G., Okamoto, K., Taya, Y., Shiloh, Y., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00562-06 · Cited by 93 · see citing works
Self-citationRegulation of p53-MDMX interaction by casein kinase 1 alpha
Chen, L., Li, C., Pan, Y., & Chen, J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6509-6520.2005 · Cited by 88 · see citing works
Regulation of MDMX Expression by Mitogenic Signaling
Gilkes, D. M., Pan, Y., Coppola, D., Yeatman, T., Reuther, G. W., & Chen, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01633-07 · Cited by 82 · see citing works
Wang, Y. V., Leblanc, M., Wade, M., Jochemsen, A. G., & Wahl, G. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.008 · Cited by 79 · see citing works
Self-citationMdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase
Okamoto, K., Taya, Y., & Nakagama, H. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.07.021 · Cited by 76 · see citing works
Mdmx promotes genomic instability independent of p53 and Mdm2
Carrillo, A. M., Bouska, A., Arrate, M. P., & Eischen, C. M. (2015) · Oncogene · doi:10.1038/onc.2014.27 · Cited by 69 · see citing works
Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway
Bang, S., Kaur, S., & Kurokawa, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010261 · Cited by 69 · see citing works
MDMX inhibits the p300/CBP-mediated acetylation of p53
Sabbatini, P., & McCormick, F. (2002) · DNA and Cell Biology · doi:10.1089/104454902320219077 · Cited by 62 · see citing works
Giglio, S., Mancini, F., Gentiletti, F., Sparaco, G., Felicioni, L., Barassi, F., Martella, C., Prodosmo, A., Iacovelli, S., Buttitta, F., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0450 · Cited by 58 · see citing works
Role of Mdm4 in drug sensitivity of breast cancer cells
Lam, S., Lodder, K., Teunisse, A. F. A. S., Rabelink, M. J. W. E., Schutte, M., & Jochemsen, A. G. (2010) · Oncogene · doi:10.1038/onc.2009.522 · Cited by 52 · see citing works
Self-citationStructural and Functional Comparison of the RING Domains of Two p53 E3 Ligases, Mdm2 and Pirh2
Shloush, J., Vlassov, J. E., Engson, I., Duan, S., Saridakis, V., Dhe-paganon, S., Raught, B., Sheng, Y., & Arrowsmith, C. H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.157669 · Cited by 42 · see citing works
De Clercq, S., Gembarska, A., Denecker, G., Maetens, M., Naessens, M., Haigh, K., Haigh, J. J., & Marine, J.-C. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00330-10 · Cited by 35 · see citing works
Cytoplasmic tethering is involved in synergistic inhibition of p53 by Mdmx and Mdm2
Ohtsubo, C., Shiokawa, D., Kodama, M., Gaiddon, C., Nakagama, H., Jochemsen, A. G., Taya, Y., & Okamoto, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01180.x · Cited by 32 · see citing works
- Authors
- Stad, R., Little, N. A., Xirodimas, D. P., Frenk, R., van der Eb, A. J., Lane, D. P., Saville, M. K., & Jochemsen, A. G.
- Affiliations
- Leiden University Medical Center (NL)
- University of Dundee (GB)
- Venue
- The EMBO Reports
- Published
- 2001-11-01
- Volume
- 2
- Issue
- 11
- Pages
- 1029-1034
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC1084126
- OpenAlex
- W1982545718
- Semantic Scholar
- 9a1a4f2eec163e17e139e410aef986cb5dffe4d8
- Cited by
- 234
- References
- 16
- Citations by year
- 2025: 5 · 2024: 3 · 2023: 7 · 2022: 4 · 2021: 9 · 2020: 7 · 2019: 5 · 2018: 5 · 2017: 8 · 2016: 6 · 2015: 2 · 2014: 17 · 2013: 5 · 2012: 13
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- EMBO Reports (publishedVersion)
- PubMed Central (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- KWF Kankerbestrijding
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- MDMX, p53 stabilization, MDM2, protein stability, ubiquitination, proteasomal degradation, ubiquitin ligase, tumor suppressor regulation
- MeSH terms
- Animals, Cell Cycle, Cell Line, Cell Nucleus, Cytoplasm, Humans, Ligases, Microscopy, Fluorescence, Mutation, Nuclear Proteins, Plasmids, Protein Binding, Proto-Oncogene Proteins, Transfection, Tumor Suppressor Protein p53, Apoptosis, Protein Structure, Tertiary, Mice, Knockout, Dimerization, Active Transport, Cell Nucleus, Ubiquitin, Ubiquitin-Protein Ligases, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-08.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-08.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review